CannDo Pharma recently participated in Bio HealthTech International 2026 at BITEC Bangkok, exhibiting under the Science and Technology Park, Chiang Mai University (STeP) through our collaboration with Chiang Mai University. The event brought together the biotechnology, pharmaceutical, healthcare, and innovation communities, with business networking and matching forming an important part of the programme.
The event provided an excellent opportunity to showcase CannDo Pharma and Lepsia to an international audience, while engaging with companies, industry professionals, and potential partners through our exhibition booth and business-matching sessions.
We were pleased to see strong interest in our recent achievements, particularly our PIC/S GMDP certification and the Thai FDA registration of Lepsia. These milestones represent the continued progress of CannDo Pharma and the dedication of our team to building pharmaceutical capabilities that meet high standards of quality.
Our participation also created valuable new connections and opened discussions around potential opportunities for future international collaboration.
We sincerely thank Chiang Mai University and STeP for providing CannDo Pharma with the opportunity and platform to showcase our work to the global life sciences community.
